Collegium Pharmaceutical awards 50,305 RSUs to 34 newly hired employees under inducement plan

Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc.

COLL

0.00
  • Collegium Pharmaceutical awarded 50,305 restricted stock units on June 1, 2026 under its 2026 Inducement Plan.
  • Grants covered 34 newly hired, non-executive employees; each RSU converts into one common share upon vesting.
  • Vesting starts June 10, 2027 for one-third, with the remainder vesting in equal annual installments over the next two years.
  • RSUs will be settled in common stock on each vesting date, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collegium Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606050800PRIMZONEFULLFEED9731327) on June 05, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.